Molecular Pharmacology Fast Forward
First published on June 30, 2004; DOI: 10.1124/mol.104.001487
0026-895X/04/6604-880-889$20.00
Mol Pharmacol 66:880-889, 2004
Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling
Valérie Capra,
Alessio Veltri,
Chiara Foglia,
Luca Crimaldi,
Aïda Habib,
Marco Parenti, and
G. Enrico Rovati
Laboratory of Molecular Pharmacology, Section of Theoretical and Receptor Pharmacology, Department of Pharmacological Sciences, University of Milan, Milan, Italy (V.C., A.V., C.F., G.E.R.); Institut National de la Sante et de la Recherche Medicale U348, IFR Circulation-Paris-Nord, Hôpital Lariboisière, Paris, France (V.C., A.H.); Departments of Biochemistry and Internal Medicine, American University of Beirut, Beirut, Lebanon (A.H.); and Department of Experimental and Environmental Medicine and Medical Biotechnologies, University of Milan Bicocca, Milan, Italy (L.C., M.P.)
The presence of highly conserved amino acid stretches in G protein-coupled receptors (GPCRs) usually predicts an important role in receptor function. Considerable attention has therefore been focused on the involvement of the highly conserved Glu/Asp-Arg-Tyr (E/DRY) motif at the cytoplasmic end of transmembrane domain 3 in the regulation of GPCR conformational states and/or the mediation of G protein activation. In the present study, we investigated the role of Glu129 and Arg130 in the ERY of thromboxane A2 receptor
(TP
) in transfected human embryonic kidney 293 cells. We show that no conservative or nonconservative substitutions of Glu129 and Arg130 generated a constitutively active TP
mutant, but a nonconservative mutation of Arg130 (R130V) yielded a mutant receptor with significantly impaired 9,11-dideoxy-9
,11
-methanoepoxy-prosta-5Z,13E-dien-1-oic acid (U46619)-induced accumulation of inositol phosphates (IPs). This loss-of-function phenotype seems to be caused by the uncoupling of the TP
receptor from Gq, as demonstrated by the loss of high-affinity agonist binding, and not by receptor internalization, as shown by localization studies with the R130V-green fluorescent protein fusion protein. It is interesting to note that U46619-induced activation of the nonconservative E129V mutant stimulated the production of IPs with a
10-fold lower EC50 and a
2-fold higher Emax than in the wild-type receptor. Collectively, these data demonstrate that, unlike other GPCRs, mutations of Glu129 do not induce constitutive activity, whereas Arg130 is involved in G protein coupling or recognition, and they suggest the existence within class A GPCRs of at least two different subclasses that make different uses of the highly conserved E/DRY motif.
Received April 21, 2004;
accepted June 30, 2004
Address correspondence to: Dr. Valérie Capra, Laboratory of Molecular Pharmacology, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. E-mail: valerie.capra{at}unimi.it
This article has been cited by other articles:

|
 |

|
 |
 
E. Peverelli, A. G. Lania, G. Mantovani, P. Beck-Peccoz, and A. Spada
Characterization of Intracellular Signaling Mediated by Human Somatostatin Receptor 5: Role of the DRY Motif and the Third Intracellular Loop
Endocrinology,
July 1, 2009;
150(7):
3169 - 3176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Proulx, B. J. Holleran, A. A. Boucard, E. Escher, G. Guillemette, and R. Leduc
Mutational Analysis of the Conserved Asp2.50 and ERY Motif Reveals Signaling Bias of the Urotensin II Receptor
Mol. Pharmacol.,
September 1, 2008;
74(3):
552 - 561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Case, E. Sharp, T. Benned-Jensen, M. M. Rosenkilde, N. Davis-Poynter, and H. E. Farrell
Functional Analysis of the Murine Cytomegalovirus Chemokine Receptor Homologue M33: Ablation of Constitutive Signaling Is Associated with an Attenuated Phenotype In Vivo
J. Virol.,
February 15, 2008;
82(4):
1884 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tokunaga, B. Matsuura, M. Dong, L. J. Miller, T. Ueda, S. Furukawa, Y. Hiasa, and M. Onji
Mutational analysis of predicted intracellular loop domains of human motilin receptor
Am J Physiol Gastrointest Liver Physiol,
February 1, 2008;
294(2):
G460 - G466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Angelova, F. Fanelli, and D. Puett
Contributions of Intracellular Loops 2 and 3 of the Lutropin Receptor in Gs Coupling
Mol. Endocrinol.,
January 1, 2008;
22(1):
126 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Binet, B. Duthey, J. Lecaillon, C. Vol, J. Quoyer, G. Labesse, J.-P. Pin, and L. Prezeau
Common Structural Requirements for Heptahelical Domain Function in Class A and Class C G Protein-coupled Receptors
J. Biol. Chem.,
April 20, 2007;
282(16):
12154 - 12163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Rovati, V. Capra, and R. R. Neubig
The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
Mol. Pharmacol.,
April 1, 2007;
71(4):
959 - 964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Buccellati, A. Sala, G. Rossoni, V. Capra, G. E. Rovati, A. Di Gennaro, G. Folco, S. Colli, and C. Casagrande
Pharmacological Characterization of 2NTX-99 [4-Methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a Potential Antiatherothrombotic Agent with Antithromboxane and Nitric Oxide Donor Activity in Platelet and Vascular Preparations
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
830 - 837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Capra, S. Ravasi, M. R. Accomazzo, S. Citro, M. Grimoldi, M. P. Abbracchio, and G. E. Rovati
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation
J. Cell Sci.,
December 1, 2005;
118(23):
5625 - 5636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Hawtin
Charged Residues of the Conserved DRY Triplet of the Vasopressin V1a Receptor Provide Molecular Determinants for Cell Surface Delivery and Internalization
Mol. Pharmacol.,
October 1, 2005;
68(4):
1172 - 1182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Rosenkilde, T. N. Kledal, and T. W. Schwartz
High Constitutive Activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY Motif (Asp-Arg-Tyr) in Transmembrane Helix 3
Mol. Pharmacol.,
July 1, 2005;
68(1):
11 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics